Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · IEX Real-Time Price · USD

3.850

+0.150 (4.05%)

At close: May 1, 2024, 4:00 PM

3.760

-0.090 (-2.34%)

After-hours: May 1, 2024, 4:07 PM EDT

Atea Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	324	254	401	743	3,452
Market Cap Growth	-	-36.48%	-46.08%	-78.48%	-
Enterprise Value	-252	-321	-243	-22	2,602
PE Ratio	-1.87	-1.87	-3.46	6.13	-315.31
PS Ratio	-	-	-	2.11	70.97
PB Ratio	0.58	0.46	0.63	1.05	6.30
P/FCF Ratio	-2.98	-2.98	-3.26	-8.54	11.63
P/OCF Ratio	-2.98	-2.98	-3.31	-8.54	11.63
EV/Sales Ratio	-	-	-	-0.06	53.49
EV/EBITDA Ratio	2.39	2.39	2.04	-0.16	-238.07
EV/EBIT Ratio	2.38	2.38	2.03	-0.16	-237.66
EV/FCF Ratio	3.76	3.76	1.98	0.25	8.77
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	0.00	-
Debt / FCF Ratio	-0.03	-0.03	-0.03	0.00	-
Quick Ratio	17.86	17.86	35.01	13.44	2.71
Current Ratio	18.24	18.24	35.77	13.58	2.73
Asset Turnover	0	0	0	0.42	0.11
Return on Equity (ROE)	-23.10%	-23.10%	-17.50%	19.60%	-4.40%
Return on Assets (ROA)	-22.00%	-22.00%	-16.80%	14.60%	-2.50%
Return on Capital (ROIC)	-29.44%	-29.44%	-20.30%	17.04%	-2.01%
Earnings Yield	-41.96%	-53.43%	-28.93%	16.31%	-0.32%
FCF Yield	-26.35%	-33.56%	-30.68%	-11.71%	8.60%
Buyback Yield / Dilution	-0.17%	-0.17%	5.67%	-308.70%	-113.98%
Total Shareholder Return	-0.17%	-0.17%	5.67%	-308.70%	-113.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).